PCM
ABMD

Price Capital Management’s Abiomed Inc ABMD Stock Holding History

Price Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,444
Closed -$1.58M – 147
2017
Q4 		$1.58M Buy
+8,444
New +$1.58M 0.55% 80
2015
Q2 		– Sell
-9,889
Closed -$708K – 232
2015
Q1 		$708K Sell
9,889
-31,195
-76% -$1.69M 0.44% 102
2014
Q4 		$1.56M Buy
+41,084
New +$1.3M 1.38% 25

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Price Capital Management's ABMD Position: Q1 2018 in Review

Price Capital Management sold out of Abiomed Inc (ABMD) in Q1 2018, closing a stake of 8,444 shares — an estimated $1.58M sold.

Price Capital Management first reported a position in ABMD in Q4 2014 and held it in 3 quarters. The position peaked at $1.58M in Q4 2017. 405 funds tracked by Wall St. Rank hold ABMD as of Q1 2018.

  • Price Capital Management reported no remaining Abiomed Inc position as of Q1 2018 after selling out during the quarter.
  • Price Capital Management sold 8,444 Abiomed Inc shares in Q1 2018, an estimated $1.58M.
  • Price Capital Management first reported a position in Abiomed Inc in Q4 2014 and held it in 3 quarters.
  • Price Capital Management's Abiomed Inc position peaked at $1.58M in Q4 2017.
  • 405 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2018.

Based on Price Capital Management's 13F filing for Q1 2018, filed 1 May 2018.